1 not yet recruiting, 1 recruiting, 1 unknown. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Not yet recruiting 1, Recruiting 1, Unknown 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Cefoxitin: new trials by email Literature Review of Cefoxitin trials Research Report on Cefoxitin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours), Ceftriaxone for Injection, Amoxicillin - Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection | Phase 2 | Not yet recruiting | The University of Queensland | 300 | 2027-04-01 | 2026-03-20 |
| Finding the Optimal Regimen for Mycobacterium Abscessus Treatment Amikacin, Tigecycline, Imipenem - Pulmonary Disease Due to Mycobacteria (Diagnosis) | Phase 2 / Phase 3 | Recruiting | The University of Queensland | 300 | 2020-03-02 | 2026-05-11 |
| Two-drug Antibiotic Prophylaxis in Scheduled Cesarean Deliveries Azithromycin 500 mg, Mefoxin 2g - Endometritis, Cesarean Section; Infection | Phase 2 | Unknown | RWJ Barnabas Health at Jersey City Medical Center | 800 | 2019-09-15 | 2019-09-17 |
Infections (2) · Mycobacterium Infections, Nontuberculous (2) · Disease (1) · Endometritis (1) · Lung Diseases (1) · Wound Infection (1)
The University of Queensland (2) · RWJ Barnabas Health at Jersey City Medical Center (1)
Australia (1) · Denmark (1) · Israel (1) · Netherlands (1) · Singapore (1) · Taiwan (1) · United Kingdom (1) · United States (1)